Rapid Micro Biosystems, Inc. (RPID)
NASDAQ: RPID · Real-Time Price · USD
3.130
-0.115 (-3.54%)
At close: Jan 9, 2026, 4:00 PM EST
3.190
+0.060 (1.92%)
After-hours: Jan 9, 2026, 6:14 PM EST
Rapid Micro Biosystems Market Cap
Rapid Micro Biosystems has a market cap or net worth of $138.73 million as of January 9, 2026. Its market cap has increased by 258.19% in one year.
Market Cap
138.73M
Enterprise Value
102.06M
1-Year Change
258.19%
Ranking
Category
Stock Price
$3.13
Market Cap Chart
Since the IPO on July 15, 2021, Rapid Micro Biosystems's market cap has decreased from $799.07M to $138.73M, a decrease of -82.64%. That is a compound annual growth rate of -32.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 143.83M | 11.90% |
| Dec 31, 2025 | 128.54M | 231.87% |
| Dec 31, 2024 | 38.73M | 23.41% |
| Dec 29, 2023 | 31.38M | -33.87% |
| Dec 30, 2022 | 47.45M | -89.21% |
| Dec 31, 2021 | 439.99M | -44.94% |
| Jul 15, 2021 | 799.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 992.16B |
| Johnson & Johnson | 499.90B |
| AbbVie | 412.54B |
| UnitedHealth Group | 309.53B |
| AstraZeneca | 297.23B |
| Novartis AG | 273.49B |
| Merck & Co. | 269.55B |
| Novo Nordisk | 254.60B |